# HCW Biologics Inc.: Form 8-K, filed Feb 19, 2026

- Company: [HCW Biologics Inc.](/companies/hcwb.md) (CIK 1828673)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 21:43 ET
- Period: 2026-02-17
- Accession: 0001193125-26-059578
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1828673/000119312526059578/hcwb-20260217.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1828673/000119312526059578/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1828673/000119312526059578/hcwb-20260217.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-059578. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.